Hy2Care (Series A)

Funding Details
Awarder
Inbox
Date Award
May 16, 2025
Vertical
Medtech
Funding URL
View Funding Page
Funding Amount:
$4,500,000

Company Info
Founding Year
2014
Traction
Hy2Care is preparing for a US clinical trial and commercial expansion following FDA IDE approval.
Founders
Marcel Karperien, Dr. Sanne Both
Company Description
Hy2Care develops innovative hydrogel-based implants for repairing damaged cartilage, offering a minimally invasive treatment that supports natural tissue regeneration.
Market
Healthcare
Location
Netherlands
Coinvestors
European Innovation Council Fund, LIOF

Links